Live Breaking News & Updates on Mitocarex Bio

Stay updated with breaking news from Mitocarex bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

SciSparc : MitoCareX Update - Form 6-K -March 13, 2024 at 09:09 am EDT

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

Report of Foreign Private Issuer

. ....

United States , Tel Aviv , Oz Adler , Scisparc Ltd , Mitocarex Bio Ltd , Company Or Scisparc , Securities Exchange , Exchange Commission , Foreign Private Issuer , Securities Exchange Act , Wallenberg Street , Mitocarex Bio , Alon Silberman , Private Securities Litigation Reform Act , Annual Report , Executive Officer , Chief Financial Officer ,

SciSparc: MitoCareX Reveals Promising Results with Discovery of Novel Anti-Cancer Small Molecule Structure -March 12, 2024 at 08:15 am EDT

MitoCareX Bio dedicates efforts to creating a predictive AI model to predict small molecules more efficiently TEL AVIV, Israel, March 12, 2024 SciSparc Ltd. , a specialty clinical-stage. ....

Exchange Commission , Company Or Scisparc , Scisparc Ltd , Mitocarex Bio Ltd , Mitocarex Bio , Alon Silberman , Tourette Syndrome , Looking Statements , Private Securities Litigation Reform Act , Annual Report ,

SciSparc: MitoCareX Reveals Promising Results with Discovery of Novel Anti-Cancer Small Molecule Structure

MitoCareX Bio dedicates efforts to creating a predictive AI model to predict small molecules more efficiently TEL AVIV, Israel, March 12, 2024 (GLOBE NEWSWIRE) SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, today announced that MitoCareX Bio Ltd. ("MitoCareX "), the Company’s venture with Dr. Alon Silberman that focuses on drug discovery and the ....

Company Or Scisparc , Mitocarex Bio Ltd , Exchange Commission , Scisparc Ltd , Mitocarex Bio , Alon Silberman , Tourette Syndrome , Looking Statements , Private Securities Litigation Reform Act , Annual Report ,

SciSparc: MitoCareX Reveals Promising Results with

MitoCareX Bio dedicates efforts to creating a predictive AI model to predict small molecules more efficiently TEL AVIV, Israel, March 12, 2024 (GLOBE. ....

Company Or Scisparc , Scisparc Ltd , Exchange Commission , Mitocarex Bio Ltd , Mitocarex Bio , Alon Silberman , Tourette Syndrome , Looking Statements , Private Securities Litigation Reform Act , Annual Report ,

SciSparc Announces Positive Results for MitoCareX Bio with its Drug Discovery Platform

MitoCareX Bio met its second milestone as part of its joint venture agreement with the Company TEL AVIV, Israel, Dec. 13, 2023 SciSparc Ltd. , a specialty clinical-stage pharmaceutical. ....

Mitocarex Bio , Exchange Commission , Mitocarex Bio Ltd , Scisparc Ltd , Company Or Scisparc , Alon Silberman , Investment Agreement , Carex Bio , Solute Carrier Family , Tourette Syndrome , Looking Statements , Private Securities Litigation Reform Act , Annual Report ,